Vision Point Advisory Group, LLC Gsk PLC Transaction History

Vision Point Advisory Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $283,203 - $425,895	-8,722 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$42.0 - $48.25 $44,814 - $51,482	1,067 Added 13.94%	8,722 $410,000
Q3 2019 Nov 14, 2019	BUY	$40.46 - $43.52 $40,298 - $43,345	996 Added 14.96%	7,655 $321,000
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $18,478 - $20,026	469 Added 7.58%	6,659 $266,000
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $238,748 - $264,251	6,190 New	6,190 $259,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.